These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26979985)

  • 1. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.
    Foppa IM; Ferdinands JM; Chaves SS; Haber MJ; Reynolds SB; Flannery B; Fry AM
    Int J Epidemiol; 2016 Dec; 45(6):2052-2059. PubMed ID: 26979985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Vaccine; 2017 Dec; 35(52):7297-7301. PubMed ID: 29146382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.
    Feng S; Cowling BJ; Sullivan SG
    Vaccine; 2016 Mar; 34(14):1672-9. PubMed ID: 26920469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case test-negative design for studies of the effectiveness of influenza vaccine.
    Foppa IM; Haber M; Ferdinands JM; Shay DK
    Vaccine; 2013 Jun; 31(30):3104-9. PubMed ID: 23624093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.
    Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA
    BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Jackson ML; Phillips CH; Benoit J; Kiniry E; Madziwa L; Nelson JC; Jackson LA
    Vaccine; 2018 Jan; 36(5):751-757. PubMed ID: 29254838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The test-negative design for estimating influenza vaccine effectiveness.
    Jackson ML; Nelson JC
    Vaccine; 2013 Apr; 31(17):2165-8. PubMed ID: 23499601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups.
    Nunes B; Machado A; Guiomar R; Pechirra P; Conde P; Cristovão P; Falcão I
    Vaccine; 2014 Jul; 32(35):4443-4449. PubMed ID: 24962756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Ainslie KEC; Haber M; Orenstein WA
    Vaccine; 2019 Mar; 37(14):1987-1993. PubMed ID: 30833155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.
    Pierse N; Kelly H; Thompson MG; Bissielo A; Radke S; Huang QS; Baker MG; Turner N;
    Vaccine; 2016 Jan; 34(4):503-509. PubMed ID: 26685091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.
    Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK
    PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
    Jackson ML; Rothman KJ
    Vaccine; 2015 Mar; 33(11):1313-6. PubMed ID: 25659280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.
    Sullivan SG; Tchetgen Tchetgen EJ; Cowling BJ
    Am J Epidemiol; 2016 Sep; 184(5):345-53. PubMed ID: 27587721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Kwong JC; Buchan SA; Chung H; Campitelli MA; Schwartz KL; Crowcroft NS; Jackson ML; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Simor A; Smieja M; Zahariadis G; Campigotto A; Gubbay JB
    Vaccine; 2019 Jul; 37(31):4392-4400. PubMed ID: 31221563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis.
    Feng S; Cowling BJ; Kelly H; Sullivan SG
    Am J Epidemiol; 2018 Feb; 187(2):389-397. PubMed ID: 28641373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Vaccine Effectiveness in the Inpatient Setting: Evaluation of Potential Bias in the Test-Negative Design by Use of Alternate Control Groups.
    Segaloff HE; Cheng B; Miller AV; Petrie JG; Malosh RE; Cheng C; Lauring AS; Lamerato LE; Ferdinands JM; Monto AS; Martin ET
    Am J Epidemiol; 2020 Mar; 189(3):250-260. PubMed ID: 31673696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018.
    Tenforde MW; Chung J; Smith ER; Talbot HK; Trabue CH; Zimmerman RK; Silveira FP; Gaglani M; Murthy K; Monto AS; Martin ET; McLean HQ; Belongia EA; Jackson LA; Jackson ML; Ferdinands JM; Flannery B; Patel MM
    Clin Infect Dis; 2021 Aug; 73(3):386-392. PubMed ID: 32270198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
    Turbyfill C; Adams K; Tenforde MW; Murray NL; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Keipp Talbot H; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Clark Files D; Hager DN; Shehu A; Prekker ME; Frosch AE; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Lauring AS; Khan A; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; June Gordon A; Qadir N; Chang SY; Mallow C; Rivas C; Kwon JH; Halasa N; Chappell JD; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Rhoads JP; Lindsell CJ; Hart KW; McMorrow M; Surie D; Self WH; Patel MM
    Vaccine; 2022 Nov; 40(48):6979-6986. PubMed ID: 36374708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.